The United States of America, as represented by the Secretary, Department of Health and Human Services
1,498Patents
1,450Active
1,498Granted
65Portfolio score
Filing activity: Aug 24, 1982 → Jun 11, 2024 · 215 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8034334B2 | Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy | Human Necessities | 216 | Expired |
| US8211422B2 | Chimeric receptor genes and cells transformed therewith | Chemistry; Metallurgy | 172 | Expired |
| US8383099B2 | Adoptive cell therapy with young T cells | Chemistry; Metallurgy | 159 | Active |
| US8465743B2 | Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer | Physics | 144 | Active |
| US8796302B2 | Methods related to the treatment of neurodegenerative and inflammatory conditions | Human Necessities | 130 | Active |
| US9074185B2 | Adoptive cell therapy with young T cells | Chemistry; Metallurgy | 114 | Active |
| US8287857B2 | Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy | Human Necessities | 76 | Active |
| US9271833B2 | Transcatheter coronary sinus mitral valve annuloplasty procedure and coronary artery and myocardial protection device | Human Necessities | 71 | Active |
| US9765342B2 | Chimeric antigen receptors targeting B-cell maturation antigen | Chemistry; Metallurgy | 70 | Active |
| US7511032B2 | Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto | Human Necessities | 70 | Expired |
| US10078124B2 | Phantom for diffusion MRI imaging | Human Necessities | 64 | Active |
| US8283151B2 | Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes | Chemistry; Metallurgy | 57 | Active |
| US5672510A | Retroviral vectors | Chemistry; Metallurgy | 51 | Expired |
| US7928079B2 | Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates | Human Necessities | 48 | Active |
| US8846389B2 | AAV4 vector and uses thereof | Chemistry; Metallurgy | 47 | Active |
| US8454972B2 | Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen | Chemistry; Metallurgy | 46 | Active |
| US9238800B2 | Avian adenoassociated virus and uses thereof | Chemistry; Metallurgy | 39 | Active |
| US5698196A | Antibodies specific for neutrophic chemotactic factor | Emerging Cross-Sectional Technologies | 39 | Expired |
| US10166255B2 | Intracellular genomic transplant and methods of therapy | Chemistry; Metallurgy | 39 | Active |
| US9447452B2 | Selective oxidation of 5-methylcytosine by TET-family proteins | Physics | 38 | Active |
| US10051880B2 | Hydroxybutyrate ester and medical use thereof | Chemistry; Metallurgy | 37 | Active |
| US9163258B2 | Method for the treatment of obesity | Chemistry; Metallurgy | 36 | Active |
| US8388510B2 | Transcranial magnetic stimulation system and methods | Human Necessities | 36 | Active |
| US9439979B2 | Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction | Chemistry; Metallurgy | 33 | Active |
| US9044451B2 | Use of delta tocopherol for the treatment of lysosomal storage disorders | Human Necessities | 32 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.